Physician profile
Guy Lin
NPI 1346253432
$1,517.88
in general payments reported to CMS, 2019-2025
20 companies · $308 in 2025
The $308 reported for 2025 was more than what a typical Plastic Surgery Within The Head & Neck provider received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $108 · 2021: $37.27 · 2022: $85.52 · 2023: $392 · 2024: $396 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,096.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,096.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $380.94 | 2019-2025 | |
| Glaxosmithkline, LLC. | $212.35 | 2021-2025 | Nucala |
| Kaleo, INC. | $140.09 | 2020-2024 | Auvi-Q |
| Optinose US, INC. | $116.08 | 2019-2024 | |
| Stryker Corporation | $87.20 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $83.86 | 2023-2024 | Ryaltris |
| Integra Lifesciences Corporation | $73.58 | 2024-2025 | Acclarent Aera, Relieva Spinplus Nav, Trudi Probe |
| Novartis Pharmaceuticals Corporation | $69.39 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $68.89 | 2020-2022 | |
| Pfizer INC. | $57.74 | 2022-2023 | |
| Csl Behring | $33.12 | 2025 | Andembry |
| Regeneron Healthcare Solutions, INC. | $29.43 | 2019 | |
| Alk-Abello, INC | $27.48 | 2019-2020 | |
| Neurent Medical Limited | $23.44 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Inspire Medical Systems, INC. | $23.31 | 2024 | Inspire |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $22.50 | 2023 | |
| Precigen, INC. | $19.71 | 2025 | |
| Amgen INC. | $18.28 | 2025 | Tezspire |
| Medtronic USA, INC. | $15.43 | 2020 | |
| Smith+Nephew, INC. | $15.06 | 2024 | Halo, Coblation, Rapid Rhino |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.